Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04546581Phase 3Completed
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
COVIDCOVID-19SARS (Severe Acute Respiratory Syndrome)+1 more
PrincipalinvestigatorStart date: 2020-10-08
NCT04385251Completed
International SARS-CoV-2 (COVID-19) Infection Observational Study
COVIDCOVID19Dyspnea+1 more
PrincipalinvestigatorStart date: 2020-06-18

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Polizzotto, MD

Kirby Institute

Moderately Similar
2 trials

Shared therapeutic areas:

COVID-19COVIDSevere Acute Respiratory Syndrome+1 more

Worked with same sponsors:

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)National Institute of Allergy and Infectious Diseases (NIAID)+2 more
Collaborated on 1 trial
Similarity Score44%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19COVIDSARS-CoV-2+1 more
Similarity Score20%

Lorenzo Berra, MD

Massachusetts General Hospital

Related
16 trials

Shared therapeutic areas:

Severe Acute Respiratory SyndromeDyspnea
Similarity Score10%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

SARS-CoV-2COVID-19

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

COVIDCOVID-19
Similarity Score10%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2
Similarity Score10%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Dyspnea
Similarity Score5%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score5%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score5%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

COVID-19
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04546581Phase 3PrincipalInvestigator

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVIDCOVID-19SARS (Severe Acute Respiratory Syndrome)+1 more
Completed
NCT04385251PrincipalInvestigator

International SARS-CoV-2 (COVID-19) Infection Observational Study

COVIDCOVID19Dyspnea+1 more
Completed

All 2 trials loaded